Cargando…
Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance
The aim of this study was to profile the spectrum of genetic mutations in acute myeloid leukemia (AML) patients co-occurring with CEBPA double mutation (CEBPA(dm)). Between January 1, 2012, and June 30, 2017, 553 consecutive patients with de novo AML were screened for CEBPA mutations. Out of these,...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982761/ https://www.ncbi.nlm.nih.gov/pubmed/29861846 http://dx.doi.org/10.18632/oncotarget.23873 |
_version_ | 1783328305591615488 |
---|---|
author | Su, Long Tan, YeHui Lin, Hai Liu, XiaoLiang Yu, Li Yang, YanPing Liu, ShanShan Bai, Ou Yang, Yan Jin, FengYan Sun, JingNan Liu, ChunShui Liu, QiuJu Gao, SuJun Li, Wei |
author_facet | Su, Long Tan, YeHui Lin, Hai Liu, XiaoLiang Yu, Li Yang, YanPing Liu, ShanShan Bai, Ou Yang, Yan Jin, FengYan Sun, JingNan Liu, ChunShui Liu, QiuJu Gao, SuJun Li, Wei |
author_sort | Su, Long |
collection | PubMed |
description | The aim of this study was to profile the spectrum of genetic mutations in acute myeloid leukemia (AML) patients co-occurring with CEBPA double mutation (CEBPA(dm)). Between January 1, 2012, and June 30, 2017, 553 consecutive patients with de novo AML were screened for CEBPA mutations. Out of these, 81 patients classified as CEBPA(dm) were analyzed further by a sensitive next-generation sequencing assay for mutations in 112 candidate genes. Within the CEBPA gene itself, we found 164 mutations. The most common mutated sites were c.936_937insGAG (n = 11/164, 6.71%) and c.939_940insAAG (n = 11/164, 6.71%), followed by c.68dupC (n = 10/164, 6.10%). The most common co-occurring mutations were found in the CSF3R (n = 16/81, 19.75%), WT1 (n = 15/81, 18.52%), and GATA2 (n = 13/81, 16.05%) genes. Patients with CSF3R mutations had an inferior four-year relapse-free survival (RFS) than those with the wild-type gene (15.3% versus 46.8%, respectively; P = 0.021). Patients with WT1 mutations had an inferior five-year RFS compared with those without such mutations (0% versus 26.6%, respectively, P = 0.003). However, GATA2, CSF3R, WT1 mutations had no significant influence on the overall survival. There were some differences in the location of mutational hotspots within the CEBPA gene, as well as hotspots of other co-occurring genetic mutations, between AML patients from Chinese and Caucasian populations. Some co-occurring mutations may be potential candidates for refining the prognoses of AML patients with CEBPA(dm) in the Chinese population. |
format | Online Article Text |
id | pubmed-5982761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-59827612018-06-01 Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance Su, Long Tan, YeHui Lin, Hai Liu, XiaoLiang Yu, Li Yang, YanPing Liu, ShanShan Bai, Ou Yang, Yan Jin, FengYan Sun, JingNan Liu, ChunShui Liu, QiuJu Gao, SuJun Li, Wei Oncotarget Research Paper The aim of this study was to profile the spectrum of genetic mutations in acute myeloid leukemia (AML) patients co-occurring with CEBPA double mutation (CEBPA(dm)). Between January 1, 2012, and June 30, 2017, 553 consecutive patients with de novo AML were screened for CEBPA mutations. Out of these, 81 patients classified as CEBPA(dm) were analyzed further by a sensitive next-generation sequencing assay for mutations in 112 candidate genes. Within the CEBPA gene itself, we found 164 mutations. The most common mutated sites were c.936_937insGAG (n = 11/164, 6.71%) and c.939_940insAAG (n = 11/164, 6.71%), followed by c.68dupC (n = 10/164, 6.10%). The most common co-occurring mutations were found in the CSF3R (n = 16/81, 19.75%), WT1 (n = 15/81, 18.52%), and GATA2 (n = 13/81, 16.05%) genes. Patients with CSF3R mutations had an inferior four-year relapse-free survival (RFS) than those with the wild-type gene (15.3% versus 46.8%, respectively; P = 0.021). Patients with WT1 mutations had an inferior five-year RFS compared with those without such mutations (0% versus 26.6%, respectively, P = 0.003). However, GATA2, CSF3R, WT1 mutations had no significant influence on the overall survival. There were some differences in the location of mutational hotspots within the CEBPA gene, as well as hotspots of other co-occurring genetic mutations, between AML patients from Chinese and Caucasian populations. Some co-occurring mutations may be potential candidates for refining the prognoses of AML patients with CEBPA(dm) in the Chinese population. Impact Journals LLC 2018-01-03 /pmc/articles/PMC5982761/ /pubmed/29861846 http://dx.doi.org/10.18632/oncotarget.23873 Text en Copyright: © 2018 Su et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Su, Long Tan, YeHui Lin, Hai Liu, XiaoLiang Yu, Li Yang, YanPing Liu, ShanShan Bai, Ou Yang, Yan Jin, FengYan Sun, JingNan Liu, ChunShui Liu, QiuJu Gao, SuJun Li, Wei Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance |
title | Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance |
title_full | Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance |
title_fullStr | Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance |
title_full_unstemmed | Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance |
title_short | Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance |
title_sort | mutational spectrum of acute myeloid leukemia patients with double cebpa mutations based on next-generation sequencing and its prognostic significance |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982761/ https://www.ncbi.nlm.nih.gov/pubmed/29861846 http://dx.doi.org/10.18632/oncotarget.23873 |
work_keys_str_mv | AT sulong mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT tanyehui mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT linhai mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT liuxiaoliang mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT yuli mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT yangyanping mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT liushanshan mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT baiou mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT yangyan mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT jinfengyan mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT sunjingnan mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT liuchunshui mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT liuqiuju mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT gaosujun mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance AT liwei mutationalspectrumofacutemyeloidleukemiapatientswithdoublecebpamutationsbasedonnextgenerationsequencinganditsprognosticsignificance |